Cargando…
Potential of AT(1)-R-Biased Agonists in Pediatric Heart Failure
Autor principal: | Port, J. David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691276/ https://www.ncbi.nlm.nih.gov/pubmed/33296444 http://dx.doi.org/10.1016/j.jacbts.2020.09.008 |
Ejemplares similares
-
β-Arrestin–Biased AT(1) Agonist TRV027 Causes a Neonatal-Specific Sustained Positive Inotropic Effect Without Increasing Heart Rate
por: Kashihara, Toshihide, et al.
Publicado: (2020) -
Resolution of Heart Failure Inflammation
por: Bäck, Magnus
Publicado: (2022) -
Heart Failure in Pulmonary Arterial Hypertension Is Just a WNK1 Away
por: Ha, Chae-Myeong, et al.
Publicado: (2021) -
Heart Failure With Reduced Ejection Fraction Is Characterized by Systemic NEP Downregulation
por: Pavo, Imre J., et al.
Publicado: (2020) -
Glucagon Receptor Antagonism Ameliorates Progression of Heart Failure
por: Gao, Chen, et al.
Publicado: (2019)